Form 4: Clorox Executive Granted 7,208 Restricted Stock Units

Sentiment:

Statement of Changes in Beneficial Ownership


Clorox EVP-Group President Chris T Hyder received a grant of 7,208 restricted stock units, vesting over four years.

Summary

  • Chris T Hyder, EVP-Group Pres -Hlth & Hyg at Clorox Co, acquired 7,208 shares of common stock in the form of Restricted Stock Units (RSUs).
  • The transaction occurred on September 16, 2025, with a deemed price of $124.85 per share.
  • Following this acquisition, Hyder beneficially owns a total of 29,325 shares of common stock.
  • The Restricted Stock Units will vest in four equal installments, with the first vesting on October 5, 2026, and subsequent installments on October 5, 2027, 2028, and 2029.

Sentiment

Score: 7

Explanation: The grant of Restricted Stock Units to a key executive is a positive signal, indicating executive retention and alignment with shareholder interests, though it's a routine compensation event rather than a significant new development.

Positives

  • The grant of Restricted Stock Units aligns executive interests with long-term shareholder value.
  • Indicates continued commitment and retention of a key executive within the company.

Future Outlook

The vesting schedule for the Restricted Stock Units extends through October 2029, indicating a long-term incentive structure designed to retain the executive and align their performance with the company's future success.

Industry Context

Executive compensation through equity grants like Restricted Stock Units is a common practice across various industries, including consumer goods, to incentivize long-term performance and align management interests with shareholders. This grant is consistent with typical executive compensation strategies.

Comparison to Industry Standards

  • Equity-based compensation, specifically Restricted Stock Units (RSUs), is a standard practice for executive incentives in large consumer goods companies such as Procter & Gamble (PG) and Kimberly-Clark (KMB).
  • The four-year vesting schedule for these RSUs is typical for such grants, aiming to retain executives and encourage sustained performance, comparable to similar programs at industry peers.

Stakeholder Impact

  • Shareholders: Positive alignment of executive incentives with long-term shareholder value.
  • Employees: May signal stability in executive leadership and a consistent approach to compensation.

Next Steps

  • Vesting of 1/4 of the Restricted Stock Units on October 5, 2026.
  • Vesting of 1/4 of the Restricted Stock Units on October 5, 2027.
  • Vesting of 1/4 of the Restricted Stock Units on October 5, 2028.
  • Vesting of 1/4 of the Restricted Stock Units on October 5, 2029.

Key Dates

DateDescription
09/16/2025Date of transaction (grant of Restricted Stock Units)
09/18/2025Date Form 4 was signed
10/05/2026First vesting installment of Restricted Stock Units
10/05/2027Second vesting installment of Restricted Stock Units
10/05/2028Third vesting installment of Restricted Stock Units
10/05/2029Fourth and final vesting installment of Restricted Stock Units

Recommendation

hold

This Form 4 reports a routine grant of Restricted Stock Units to a senior executive, which is a standard component of executive compensation designed to align management interests with long-term shareholder value. While positive for executive retention and incentive alignment, it does not present new information that would fundamentally alter the investment thesis for Clorox, thus a 'hold' recommendation is appropriate for existing investors.

Keywords

Clorox, CLX, Restricted Stock Units, RSU, Executive Compensation, Insider Transaction, Chris T Hyder, Stock Grant

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.